within Pharmacolibrary.Drugs.ATC.D;

model D07XC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.001,
    Cl             = 0.2,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Mometasone is a synthetic corticosteroid used topically for its anti-inflammatory, antipruritic, and vasoconstrictive properties. It is commonly used in the treatment of dermatological conditions such as eczema, psoriasis, and allergic dermatitis. Mometasone is also available as a nasal spray for allergic rhinitis and as an inhaler for asthma. It is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical mometasone furoate in healthy adult subjects based on available literature and standard reference data.</p><h4>References</h4><ol><li>Fabrizio Spada, Tanya M Barnes, Kerryn A Greive,Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.,The Australasian journal of dermatology,2018<a href='https://pubmed.ncbi.nlm.nih.gov/29411351/'>https://pubmed.ncbi.nlm.nih.gov/29411351/</a></li><li>Soniya Vaidya, Dominik Ziegler, Ana-Maria Tanase, Ulf Malmqvist, Frank Kanniess, Bettina Hederer, Motoi Hosoe,Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.,Pulmonary pharmacology & therapeutics,2021<a href='https://pubmed.ncbi.nlm.nih.gov/33771722/'>https://pubmed.ncbi.nlm.nih.gov/33771722/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D07XC03;
